US gives go ahead to Alzheimer's drug

The US food and drug administration has cleared Eisai's Alzheimer's drug, Aricept, to treat severe dementia in patients with the degenerative brain disease.

    Ronald Reagan suffered from Alzheimer's

    The drug, which is also marketed by Pfizer, is already approved to treat mild to moderate dementia in patients of Alzheimer's, which affects roughly 4.5 million mostly older Americans.

    There is no cure for the condition, typified by memory loss and other cognitive impairment that can quickly worsen.

    Alzheimer's is the most common form of dementia.

    Eisai, based in Japan, earlier this month cited growing US sales of the drug thanks to Medicare's new prescription drug benefit for the elderly and disabled.

    It has forecast total Aricept sales at $1.9 billion, for the fiscal year through March 2007. Some analysts have said that estimate is conservative, but company officials have declined to comment.

    SOURCE: Reuters


    YOU MIGHT ALSO LIKE

    Senegal's village of women

    Senegal's village of women

    Women in northeast Senegal are using solar-powered irrigation to farm food and halt the encroaching desert.

    Inside Baltimore's human trafficking industry

    Inside Baltimore's human trafficking industry

    Survivors of sex trafficking and those who investigate it in the city share their stories.

    Nuclear Gulf: Is Saudi Arabia pushing itself into a nuclear trap?

    Nuclear Gulf: Is Saudi Arabia pushing itself into a nuclear trap?

    MBS is prepared to pursue nuclear weapons if Iran gets them. But could he end up making the kingdom a nuclear pawn?